Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial-Reference-Cited by-同舟云学术

Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial

Published:2016-11 Issue:5 Volume:65 Page:906-913
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Sinclair Marie,Grossmann Mathis,Hoermann Rudolf,Angus Peter W.,Gow Paul J.

Funder

Novartis

Bayer Schering

University of Melbourne

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Hepatology

Reference54 articles.

1. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis;Zietz;Eur J Gastroenterol Hepatol,2003

2. Low testosterone levels as an independent predictor of mortality in men with chronic liver disease;Grossmann;Clin Endocrinol,2012

3. Muscle wasting is associated with mortality in patients with cirrhosis;Montano-Loza;Clin Gastroenterol Hepatol,2012

4. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value;Tandon;Liver Transpl,2012

5. Low testosterone is a better predictor of mortality than sarcopenia in men with advanced liver disease;Sinclair;J Gastroenterol Hepatol,2016

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcopenia in cirrhosis: From pathophysiology to interventional therapy;Experimental Gerontology;2024-10

2. Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023;Portal Hypertension & Cirrhosis;2024-09-12

3. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond;Current Treatment Options in Gastroenterology;2024-08-23

4. Bone mineral density, sarcopenia and long-term survival in patients with cirrhosis;Indian Journal of Gastroenterology;2024-08-17

5. S2k-Leitlinie Klinische Ernährung in der Hepatologie;Aktuelle Ernährungsmedizin;2024-08